ArticleGeneral psychiatry2022
Adaptation and validation of the Chinese version of the Central Sensitisation Inventory in patients with chronic pain.
Article in General psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Psychometric properties of patient-reported outcome measures in chronic pain conditions with central sensitization- a systematic review and meta-analysis.Journal of patient-reported outcomes · 2025Pooled it
- Profile and association between pain sensitivity and physical fitness in individuals with chronic low back pain.BMC musculoskeletal disorders · 2026Article
- Correlations of The Central Sensitization Inventory, conditioned pain modulation, cognitions and psychological factors in individuals with chronic neck pain: A cross-sectional study.Pain and therapy · 2024Article
- Blink rate during saccadic eye movements: insights from patients with chronic pain.Journal of medicine and life · 2024Article
- Intermediary roles of prospective memory and retrospective memory in the comorbidity of depression and pain.General psychiatry · 2023Article
- Special issue for psychosomatic medicine.General psychiatry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The 25-item Central Sensitisation Inventory (CSI-25) is a patient-reported instrument used to screen patients at risk of central sensitisation, a pathophysiological mechanism implicated in many chronic pain syndromes. Aims: To adapt and validate a Chinese version of the CSI-25 in the Chinese population. Methods: The Chinese CSI-25 was developed by the translation of the original English version, back translation, cultural adaptation and revision using the Delphi method. The Chinese CSI-25 was administered to 237 patients with chronic pain and 55 healthy controls. Structural validity (confirmatory factor analysis), construct validity (correlations with other instruments), test-retest reliability and internal consistency were evaluated. Results: Confirmatory factor analysis extracted four main factors ('physical symptoms', 'emotional distress', 'headache/jaw symptoms' and 'urological symptoms'). The Chinese CSI-25 score was positively correlated with the Pain Catastrophic Scale (PCS) total score (r=0.709), PCS subscale scores (r=0.630-0.695), Brief Pain Inventory (BPI) mean item score (r=0.773), BPI total score (r=0.773) and the number of painful sites (r=0.636). The Chinese CSI-25 had excellent test-retest reliability (intragroup correlation coefficient=0.975) and good internal consistency (Cronbach's α=0.930 in the overall population and 0.882 in the chronic pain population). Conclusions: The Chinese CSI-25 had excellent test-retest reliability and satisfactory structural validity and construct validity. This instrument could potentially be used in China as a self-report questionnaire in both clinical practice and research settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.